MedTrace Logo

Validation of the GMFM-88 Scale and of the FAAP-O Scale in Pediatric Patients Affected by Cancer

NCT04862130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 217

Last updated 2024-01-31

No results posted yet for this study

Summary

The primary objective of this study is to validate the Gross Motor Function Measure Scale-88 (GMFM-88) on the Italian pediatric cancer population. The secondary objective is to implement the use of the GMFM-88 in clinical practice by validating a reduced panel of items that will be called the Functional Ability Assessment in Pediatric Oncology (FAAP-O) Scale.

Conditions

Sponsors & Collaborators

  • Associazione Italiana Ematologia Oncologia Pediatrica

    lead OTHER

Principal Investigators

  • Francesca Rossi, dr · A.O.U. Città della Salute e della Scienza - OIRM, Turin, Italy

Eligibility

Min Age
6 Months
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-14
Primary Completion
2020-10-30
Completion
2023-05-22

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04862130 on ClinicalTrials.gov